Financials
- Market Capitalization 443.39 M
- Employee 674
- Founded 2013
- CEO Thomas Lingelbach
- Website www.valneva.com
- Headquarter France
- FIGI BBG00ZZPBH08
- Industry Biotechnologie
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 2989 | PRTA Prothena Corporation plc - Ordinary Shares | 8.64 USD | -2.15% | -10.56% | +5.88% | +37.80% | 452.33 M USD | ||
| 3001 | BNTC Benitec Biopharma Inc. - Common Stock | 12.98 USD | -0.08% | -3.13% | +13.96% | -21.85% | 445.92 M USD | ||
| 3019 | CABA Cabaletta Bio, Inc. - Common Stock | 2.67 USD | -3.61% | -12.46% | -11.30% | +62.80% | 435.36 M USD | ||
| 3027 | EVMN Evommune, Inc. Common Stock | 12.00 USD | -0.91% | -8.33% | -42.25% | -30.72% | 432.22 M USD |